Healthcare -
Biotechnology - NASDAQ - US
$ 6.96
0 %
$ 476 M
Market Cap
-1.21
P/E
PHAT - LONG-TERM DEBT
Long-term Debt PHAT - Phathom Pharmaceuticals, Inc.
138 M
LAST VALUE
23.38%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR